Skip to content
Life Sciences Series A Founded 2018

Abselion

Provider of a benchtop instrument for protien research

📍 Cambridge, United Kingdom · Life Sciences Platforms and Tools

Funding snapshot

Last roundSeries A
Amount$8M
Date28 October 2024

About

Provider of a benchtop instrument for protien research. It offers Amperia which is integrated with 96-well plates and based on Redox Electrochemical Detection technology that tracks electrical alterations when interacted with molecules for antibody quantification or binding assays.

Latest news

No articles yet.

Raising like Abselion?

Analyze your pitch deck before your next raise.

Analyze My Deck →